Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $12.780.00 (0.00%)
Today's Open$0.00
Previous Close$12.78
Data as of 09/27/16 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $12.78 with a 52 week high of $21.00 and a 52 week low of $9.79.
Recent News

September 21, 2016

NantHealth Partners with Children’s Hospital of Orange County to Revolutionize Pediatric Cancer Care Through the Use of GPS Cancer™

GPS Cancer will allow physicians to identify personalized treatments for children with rare, refractory or recurrent cancers for whom conventional approaches have proven unsuccessful Research partnership will provide new hope for an estimated 15,780 children between the ages of birth and 19 years of age who are diagnosed with cancer each year1 CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 21, 2016-- In an effort to accelerate and improve ...

Read More >

September 07, 2016

Phoenix Children’s Hospital Selects NantHealth’s Molecular Testing Platform and Comprehensive Suite of Software Solutions for Precision Cancer Care

One of the nation’s leading pediatric hospitals to adopt GPS Cancer™, a comprehensive molecular testing platform for personalized cancer therapy, for its patients and self-insured employee population NantHealth’s decision support, patient engagement, care coordination, and analytics solutions to help Phoenix Children’s advance population health and improve value-based outcomes CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 7, 2016-- ...

Read More >

August 09, 2016

NantHealth Reports Strong 2016 Second-Quarter Revenues and Continued Progress on GPS Cancer and NantOS Platform

Total Quarterly Net Revenues Increased 167% to $31.5 Million from $11.8 Million Total Six-Month Net Revenues More than Doubled to $50.9 Million from $23.5 Million Raised Net Proceeds of Approximately $83.2 Million from Successful IPO in June 2016 GPS Progress: Increased to 200,000 Covered Cancer Lives with Three New Payer Agreements, Bringing Total to Six Payers Covering GPS ...

Read More >

Upcoming Events
There are currently no events scheduled.